VBI Vaccines Inc. Profile Avatar - Palmy Investing

VBI Vaccines Inc.

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-26…

Biotechnology
US, Cambridge [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

VBI Vaccines Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

VBI Vaccines Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of VBI Vaccines Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of VBIV's Analysis
CIK: 764195 CUSIP: 91822J103 ISIN: CA91822J2020 LEI: - UEI: -
Secondary Listings
VBIV has no secondary listings inside our databases.